Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Pilot Program from USPTO

The procedure was granted a filing date, now we have a Waiver of Patent owner summary, the next step will be 1) request for reexam - Denied or 2)request for reexam granted followed by (see below underlined). Corrections welcome.

USPTO will contact the patent owner and request the optional waiver of the right to file a patent owner’s statement after the proceeding has been granted a filing date and before the examiner begins his or her review. This will enable the USPTO in suitable cases to issue the first Office action on the merits (including an NIRC) together with or soon after the order for reexamination, and thereby reduce the pendency of the proceeding by about three to five months.

Share
New Message
Please login to post a reply